Status:
COMPLETED
Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance
Lead Sponsor:
Metabolic Technologies Inc.
Collaborating Sponsors:
Iowa State University
Conditions:
Healthy Subjects
Eligibility:
All Genders
20-30 years
Phase:
PHASE1
Brief Summary
Adenosine-triphosphate (ATP) serves as the sole energy source for muscle contraction. Therefore human performance of brief maximal exercise is limited, in part, by the availability of ATP to the contr...
Detailed Description
To date we have studied 10 subjects who have followed through with all 3 of the original interventions (Placebo, 250 mg PeakATP/d and 400 mg PeakATP/d). Currently we have received approval and are exp...
Eligibility Criteria
Inclusion
- No major medical conditions;
- Able to perform fatigue testing procedures;
- Not currently taking prescription medications;
- Not currently taking dietary supplements (a daily multi-vitamin not exceeding RDA is permitted)
Exclusion
- Major medical condition affecting metabolism or general function;
- Not able to perform fatigue testing;
- Taking prescription medications;
- Taking a dietary supplement other than a multi-vitamin not exceeding RDA
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01141504
Start Date
June 1 2010
End Date
October 1 2011
Last Update
January 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iowa State University
Ames, Iowa, United States, 50010